Company Refocus Group, Inc. Other OTC
Equities
RFCS
US75865X2027
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
J. Michael Judy
CEO | Chief Executive Officer | - | 28/13/28 |
David Schanzlin
CTO | Chief Tech/Sci/R&D Officer | - | 01/12/01 |
Selene A. Burke
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/01 |
David G. Ozinga
PRN | Corporate Officer/Principal | - | 01/08/01 |
Corporate Officer/Principal | - | 01/03/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 01/11/01 | |
Thomas M. Loarie
CHM | Chairman | - | 01/14/01 |
Thomas Lyles
BRD | Director/Board Member | - | 01/05/01 |
J. Michael Judy
CEO | Chief Executive Officer | - | 28/13/28 |
Donald Phillips
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,669,105 | 24,669,105 ( 100.00 %) | 0 | 100.00 % |
Stock B | 0 | 760,000 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+30.39% | 48.16B | |
-0.65% | 41.73B | |
+43.79% | 41.03B | |
-5.31% | 28.77B | |
+10.48% | 25.59B | |
-22.49% | 18.96B | |
+9.16% | 12.92B | |
+28.71% | 12.03B | |
-2.27% | 11.77B |